Atlas Private Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,089
Closed -$777K 139
2025
Q4
$777K Buy
8,089
+270
+3% +$26.2K 0.18% 67
2025
Q3
$745K Sell
7,819
-7,164
-48% -$659K 0.18% 67
2025
Q2
$1.31M Sell
14,983
-905
-6% -$76.7K 0.17% 71
2025
Q1
$1.43M Buy
15,888
+1,560
+11% +$140K 0.2% 62
2024
Q4
$1.14M Buy
14,328
+2,430
+20% +$210K 0.16% 70
2024
Q3
$1.07M Buy
11,898
+1,164
+11% +$97.9K 0.16% 63
2024
Q2
$845K Buy
10,734
+6,359
+145% +$521K 0.14% 71
2024
Q1
$381K Buy
4,375
+591
+16% +$50.4K 0.13% 75
2023
Q4
$312K Buy
+3,784
New +$288K 0.06% 117
2021
Q4
Sell
-206
Closed -$26K 484
2021
Q3
$26K Sell
206
-16
-7% -$2.07K 0.01% 311
2021
Q2
$28K Sell
222
-179
-45% -$22.5K 0.02% 302
2021
Q1
$47K Buy
401
+170
+74% +$19.9K 0.03% 239
2020
Q4
$27K Buy
231
+25
+12% +$2.75K 0.02% 296
2020
Q3
$21K Hold
206
0.02% 298
2020
Q2
$19K Buy
+206
New +$19.8K 0.02% 323

Other funds holding MDT

Atlas Private Wealth Advisors's MDT Position: Q1 2026 in Review

Atlas Private Wealth Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 8,089 shares — an estimated $777K sold.

Atlas Private Wealth Advisors first reported a position in MDT in Q2 2020 and held it in 15 quarters. The position peaked at $1.43M in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Atlas Private Wealth Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Atlas Private Wealth Advisors sold 8,089 Medtronic shares in Q1 2026, an estimated $777K.
  • Atlas Private Wealth Advisors first reported a position in Medtronic in Q2 2020 and held it in 15 quarters.
  • Atlas Private Wealth Advisors's Medtronic position peaked at $1.43M in Q1 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Atlas Private Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.